Loading mutual fund details…
DSP Healthcare Fund - Direct Plan - Growth is an equity scheme managed by DSP Mutual Fund. Over rolling three-year windows since inception, investors earned a median compounded return of 21.81%, with the bottom and top quartiles at 18.64% and 23.45% respectively. It has ranked in the top half of its category for 2 of the last 2 reported years. The total expense ratio is 0.79% on assets of ₹3,142Cr. The fund is currently managed by Chirag Dagli, appointed within the last year.
Lower is better.
This scheme classifies as Large-Blend on the 3x3 equity style box, with 64% of its portfolio classified as of 2026-05-29.
| Holding | Sector |
|---|
| Window | Min | P25 | Median |
|---|
Point-in-time CAGRs cherry-pick a single start date. The chart below shows the distribution of every possible rolling start over the fund's history, so you see the range of investor outcomes — not just one date's number.
Backtested SIP outcomes across both rolling-window scenarios and named historical stress events (COVID, Election uncertainty, Russia/Ukraine, etc.), plus per-manager alpha during their tenure on this scheme.
Same fund, monthly SIPs over rolling 1/3/5-year windows.
| Scheme | AMC | AUM | TER | 3Y |
|---|
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. Past performance is not indicative of future results. MintByte is an AMFI-registered Mutual Fund Distributor (ARN-314872) and APMI member (APRN-01658). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Star ratings on this page reflect a 3-year category-quartile position computed in-house and are educational only.
Mutual fund schemes are subject to market risk. Read all scheme-related documents carefully before investing. Past performance is not indicative of future results. MintByte is an AMFI-registered mutual fund distributor (ARN-314872). MintByte does not issue buy/sell recommendations on specific securities — the site is an educational data and analytics platform. Not investment advice. Methodology · How we earn.
In-house derivations using 3-year daily NAV vs benchmark. See methodology.
| Weight |
|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Healthcare | 8.84% |
| IPCA LABORATORIES LIMITED | Healthcare | 8.26% |
| CIPLA LIMITED | Healthcare | 7.56% |
| LAURUS LABS LIMITED | Healthcare | 6.42% |
| Sai Life Sciences Limited | Healthcare | 6.10% |
| GLAND PHARMA LIMITED | Healthcare | 5.13% |
| APOLLO HOSPITALS ENTERPRISE LIMITED | Healthcare | 4.73% |
| ALEMBIC PHARMACEUTICALS LIMITED | Healthcare | 3.43% |
| VIJAYA DIAGNOSTIC CENTRE LIMITED | Healthcare | 3.36% |
| PFIZER LIMITED | Healthcare | 3.01% |
| KOVAI MEDICAL CENTER & HOSPITAL LIMITED | Healthcare | 2.97% |
| PROCTER & GAMBLE HEALTH LIMITED | Healthcare | 2.64% |
| INDOCO REMEDIES LIMITED | Healthcare | 2.16% |
| EMCURE PHARMACEUTICALS LIMITED | Healthcare | 2.01% |
| CONCORD BIOTECH LIMITED | Healthcare | 1.81% |
| UNICHEM LABORATORIES LIMITED | Healthcare | 1.06% |
| AARTI DRUGS LIMITED | Healthcare | 1.02% |
| ALKEM LABORATORIES LIMITED | Healthcare | 0.64% |
| MEDPLUS HEALTH SERVICES LIMITED | Consumer Cyclical | 0.53% |
| JUPITER LIFE LINE HOSPITALS LIMITED | Healthcare | 0.37% |
| Laxmi Dental Limited | Healthcare | 0.18% |
| CORONA REMEDIES PRIVATE LIMITED | Healthcare | 0.15% |
| Sector | Holdings | Weight |
|---|---|---|
| Healthcare | 21 | 77.75% |
| Financial Services | — | 1.35% |
| Consumer Services | — | 0.53% |
Active bets vs the average Equity fund. Biggest deviations shown first.
Accent bar = fund's actual sector weight. Vertical black tick = category average for the same sector. Green overlay = overweight, dashed red = underweight. The biggest active bets show first.
How crowded into the same stocks is this fund vs the largest fund in its category?
Category leader = highest-AUM scheme in the same SEBI category. A high overlap-of-weight number means the fund is concentrated into the same names as the leader (crowded); a low one means it's genuinely differentiated.
| P75 |
|---|
| Max |
|---|
| Positive % |
|---|
| 1Y | -14.02% | -0.12% | 17.15% | 40.17% | 64.73% | 74.6% |
| 3Y | 14.65% | 18.64% | 21.81% | 23.45% | 28.91% | 100.0% |
| 5Y | 14.25% | 15.77% | 18.05% | 20.45% | 25.29% | 100.0% |
Each cell is one year. Q1 = top quartile within the AMFI category for that period. Cell label is the last two digits of the year.
Top-10 weight 56.8% means concentration is in line with most actively-managed Indian equity funds. Effective-N is the inverse Herfindahl index — a measure of "how many positions effectively drive the fund" after weighting. Category: Equity.
Compounding maths on a notional ₹10 lakh lumpsum at 12% gross annual return. Green bar is what you'd have without the fee; red overlay is the fee drag. Fee is constant in this scenario — actual outcomes depend on real returns and any future TER changes.
What an investor SIPping into this fund actually got during named market shocks.
Each row is a back-tested SIP — monthly contribution over the regime's duration, no fees adjustment beyond NAV-baked TER. XIRR is the annualised IRR of those cashflows; Abs return is the absolute cash-on-cash; Max DD is the deepest drawdown experienced mid-investment. Past performance is not indicative of future results.
Alpha is the annualised excess return vs benchmark over the manager's tenure on this scheme. Beat-benchmark = total return beat the index over the same window.
| 5Y |
|---|
| Star |
|---|
| UTI Healthcare Fund - Direct Plan - Growth Option | UTI Mutual Fund | ₹1,144 Cr | 1.36% | +26.82% | +14.83% | 3★ |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | SBI Mutual Fund | ₹4,323 Cr | 0.92% | +25.57% | +16.27% | 3★ |
| ITI Pharma and Healthcare Fund - Direct Plan - Growth Option | ITI Mutual Fund | ₹230 Cr | 3.11% | +21.39% | — | 3★ |
| ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option | ITI Mutual Fund | ₹230 Cr | 3.11% | +21.38% | — | 3★ |
| Kotak Healthcare Fund - Direct Plan - Growth Option | Kotak Mahindra Mutual Fund | ₹496 Cr | 0.91% | — | — | 3★ |
| Kotak Healthcare Fund - Direct Plan - IDCW Option | Kotak Mahindra Mutual Fund | ₹496 Cr | 0.91% | — | — | 2★ |
| WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth | WhiteOak Capital Mutual Fund | ₹603 Cr | 0.86% | — | — | 3★ |
| PGIM India Healthcare Fund - Direct Plan - IDCW Option | PGIM India Mutual Fund | ₹92 Cr | 0.75% | — | — | 1★ |
| PGIM India Healthcare Fund - Direct Plan - Growth Option | PGIM India Mutual Fund | ₹92 Cr | 0.75% | — | — | 1★ |
| Bandhan Healthcare Fund - Direct Plan - Growth | Bandhan Mutual Fund | ₹291 Cr | 0.87% | — | — | — |